These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 6565051)
1. [Urinary kallikrein and prostaglandin excretion in patients with chronic glomerulonephritis of hypertensive type and the effect of kallidinogenase on its abnormality]. Mune M; Morishita S; Gotoh T; Saika Y; Yamada Y; Yukawa S; Nomoto H Nihon Jinzo Gakkai Shi; 1984 Feb; 26(2):213-20. PubMed ID: 6565051 [No Abstract] [Full Text] [Related]
2. Exaggerated fractional sodium excretion in hypertension with advanced renal disease: the role of renal prostaglandin and kallikrein. Abe K; Imai Y; Sato M; Haruyama T; Sato K; Hiwatari M; Kasai Y; Itoh S; Yasujima M; Seino M; Yoshinaga K Clin Sci (Lond); 1981 Dec; 61 Suppl 7():327s-330s. PubMed ID: 6914940 [TBL] [Abstract][Full Text] [Related]
3. [A substrate inhibitor analysis of the urinary excretion of tissue and plasma kallikreins in patients with chronic glomerulonephritis]. Platonova LV; Poliantseva LR; Filatova MP; Paskhina TS Urol Nefrol (Mosk); 1990; (4):38-43. PubMed ID: 2275058 [TBL] [Abstract][Full Text] [Related]
4. Urinary prostaglandins and kallikrein in essential hypertension. Weber PC; Scherer B; Held E; Siess W; Stoffel H Clin Sci (Lond); 1979 Dec; 57 Suppl 5():259s-261s. PubMed ID: 396075 [TBL] [Abstract][Full Text] [Related]
5. Effects of kallidinogenase on urinary kallikrein excretion and plasma prostanoid concentrations in patients with essential hypertension. Ogawa K; Ito T; Ban M; Motizuki M; Satake T Experientia; 1986 Sep; 42(9):1014-5. PubMed ID: 3639011 [TBL] [Abstract][Full Text] [Related]
6. Urinary excretion of prostaglandins (PGE2 and PGF2 alpha) and kallikrein in acute glomerulonephritis. Colina-Chourio JA; Rodríguez-Iturbe B; Baggio B; García R; Borsatti A Clin Nephrol; 1983 Nov; 20(5):217-24. PubMed ID: 6580982 [TBL] [Abstract][Full Text] [Related]
7. Hypotensive and natriuretic effects of nifedipine in essential hypertension. Role of renal kallikrein-kinin-prostaglandin and renin-angiotensin-aldosterone systems. Tsunoda K; Abe K; Omata K; Kudo K; Sato M; Kohzuki M; Tanno M; Seino M; Yasujima M; Yoshinaga K J Clin Hypertens; 1986 Sep; 2(3):263-70. PubMed ID: 3640807 [TBL] [Abstract][Full Text] [Related]
8. [Function of the kallikrein-kinin and prostaglandin systems of the kidneys in patients with chronic pyelonephritis]. Panfilov IuA; Kriukov NN; Baĭbursian ED Urol Nefrol (Mosk); 1989; (1):7-9. PubMed ID: 2718290 [TBL] [Abstract][Full Text] [Related]
9. Differing effects of two angiotensin converting enzyme inhibitors, captopril and CI-906, on diuresis and the urinary excretion of kallikrein and prostaglandins in spontaneously hypertensive rats. Säynävälammi P; Pörsti I; Nurmi AK; Seppälä E; Laitinen LA; Manninen V; Ylitalo P; Vapaatalo H Scand J Urol Nephrol Suppl; 1984; 79():23-7. PubMed ID: 6089314 [TBL] [Abstract][Full Text] [Related]
10. Proceedings: Urinary kallikrein under furosemide and plasma kininogen levels in normal and hypertensive rats. Croxatto HR; Roblero JS; García RL; Corthorn JH; San Martín M Acta Physiol Lat Am; 1973; 23(6):556-8. PubMed ID: 4795058 [No Abstract] [Full Text] [Related]
11. [Urinary kallikrein and prostaglandin E2 excretion before and after operation in adrenal and renal hypertensive patients]. Nigawara K; Yagihashi Y; Hitomi H; Kogawa T; Suzuki T; Funyu T; Terayama Y; Yamaya K; Igarashi R Nihon Jinzo Gakkai Shi; 1986 Apr; 28(4):469-80. PubMed ID: 3462401 [No Abstract] [Full Text] [Related]
12. Urinary kallikrein activity in the hypertension of renal parenchymal disease. Mitas JA; Levy SB; Holle R; Frigon RP; Stone RA N Engl J Med; 1978 Jul; 299(4):162-5. PubMed ID: 661889 [TBL] [Abstract][Full Text] [Related]
13. [Effects of dietary K on blood pressure, prostaglandin, and kallikrein in renovascular hypertensive rats]. Zhang HY; Li HQ; Lu MW Zhongguo Yao Li Xue Bao; 1989 Sep; 10(5):418-21. PubMed ID: 2618729 [TBL] [Abstract][Full Text] [Related]
14. [Components of kallikrein-kinin system in the urine of patients with glomerulonephritis]. Paskhina TS; Poliantseva LR; Platonova LV; Levina GO Vopr Med Khim; 1990; 36(4):62-9. PubMed ID: 2173275 [TBL] [Abstract][Full Text] [Related]
15. [Oral administration of extracted kallikrein to patients with essential arterial hypertension]. Bellini C; Carlomagno A; Piccoli A; Di Francesco L; Ferri C; Luparini RL; Germanò G; Giarrizzo C; Santucci A; Balsano F Clin Ter; 1991 Oct 15-31; 139(1-2):3-8. PubMed ID: 1837764 [TBL] [Abstract][Full Text] [Related]
16. Reduction in urinary prostaglandin excretion in the premenstrual syndrome. Piccoli A; Modena F; Calò L; Cantaro S; Avogadro A; Nardo G; Cerutti R J Reprod Med; 1993 Dec; 38(12):941-4. PubMed ID: 8120851 [TBL] [Abstract][Full Text] [Related]
17. Short-term treatment with captopril in hypertension due to acute glomerulonephritis. Parra G; Rodríguez-Iturbe B; Colina-Chourio J; García R Clin Nephrol; 1988 Feb; 29(2):58-62. PubMed ID: 3282729 [TBL] [Abstract][Full Text] [Related]
18. Urinary kallikrein in hypertensive rats. Pisano JJ; Geller R; Margolius HS; Keiser HR Acta Physiol Lat Am; 1974; 24(5):453-9. PubMed ID: 4467672 [No Abstract] [Full Text] [Related]